Publications by authors named "Claudio Altini"

Claim this Profile
O
Optimizing Glomerular Filtration Rate Estimation: A Simplified Method for Improved Accuracy and Efficiency.
Elena Solfaroli Camillocci, Davide Ciucci, Claudia Polito, Salvatore Donatiello, Antonio Napolitano, Claudio Altini

J Nucl Med Technol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDG PET/CT: The turning point in eosinophilic fasciitis diagnosis in a pediatric patient.
Elizabeth Katherine Anna Triumbari, Milena Pizzoferro, Maria Felicia Villani, Claudio Altini, Saadi Sollaku

Eur J Nucl Med Mol Imaging· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past.
Francesco Fabozzi, Maria Felicia Villani, Francesca Del Bufalo, Claudio Altini, Vittorio Cannatà

Crit Rev Oncol Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fit of biokinetic data in molecular radiotherapy: a machine learning approach.
Davide Ciucci, Bartolomeo Cassano, Salvatore Donatiello, Federica Martire, Antonio Napolitano, Claudio Altini

EJNMMI Phys· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F]FDG PET/CT advanced imaging in crucial management steps of a child affected by hypoplastic left heart syndrome.
Milena Pizzoferro, Marco Alfonso Perrone, Saadi Sollaku, Emanuele Casciani, Claudio Altini

Eur J Nucl Med Mol Imaging· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT in congenital hyperinsulinism: transforming patient's lives by molecular hybrid imaging.
Milena Pizzoferro, Gabriele Masselli, Arianna Maiorana, Emanuele Casciani, Saadi Sollaku, Claudio Altini

Am J Nucl Med Mol Imaging· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study.
Angelina Cistaro, Natale Quartuccio, Maria Carmen Garganese, Maria Felicia Villani, Claudio Altini

Eur J Nucl Med Mol Imaging· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience.
Claudio Altini, Maria F Villani, Angela Di Giannatale, Bartolomeo Cassano, Milena Pizzoferro

Nucl Med Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized dosimetry for a deeper understanding of metastatic response to high activity I-mIBG therapy in high risk relapsed refractory neuroblastoma.
Bartolomeo Cassano, Milena Pizzoferro, Silvio Valeri, Claudia Polito, Salvatore Donatiello, Claudio Altini

Quant Imaging Med Surg· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma.
Milena Pizzoferro, Bartolomeo Cassano, Claudio Altini, Antonella Cacchione, Maria Giuseppina Cefalo

Eur J Nucl Med Mol Imaging· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis